{
  "report_rows": [
    {
      "kpi": "Consolidated Organic Revenue Growth (ex-contingents)",
      "prediction": "MISS",
      "answer": "pred ~1.5% vs. cons ~2.6%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted Diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$1.11 vs. cons ~$1.09",
      "confidence": "HIGH"
    },
    {
      "kpi": "Total Revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$1.73B vs. cons ~$1.72B",
      "confidence": "HIGH"
    }
  ],
  "guide_rows": [
    {
      "kpi": "FY2026 Organic Revenue Growth outlook/commentary",
      "prediction": "LOWER",
      "answer": "guide ~3.0% vs. cons ~4.0% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "FY2026 Adjusted EBITDAC Margin Expansion",
      "prediction": "LOWER",
      "answer": "guide ~+20bps vs. cons ~+40bps (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Accession/Risk Strategies EBITDA Synergy Target",
      "prediction": "UNCHANGED",
      "answer": "guide ~$35M vs. cons ~$35M (FY2026, midpoint of $30-40M range reaffirmed)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Howden litigation annualized lost revenue trajectory",
      "prediction": "LOWER",
      "answer": "guide/actual ~$36M vs. prior-quarter ~$31M (Q2 2026 cumulative, deceleration not yet evident)",
      "confidence": "LOW"
    }
  ],
  "day1_residual_pct": -4.0,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": -6.5,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "Peer read-throughs (MMC/Guy Carpenter Q2 results showing global property cat rate declines accelerating to -16% at midyear from -12% in Q1, with Guy Carpenter posting negative organic growth) confirm the CAT-property pricing headwind BRO flagged is intensifying rather than stabilizing, undercutting management's promised sequential organic-growth improvement into Q2/H2. Even with a modest EPS beat driven by contingents and buybacks, the out-period math means FY26 organic growth and margin-expansion estimates get trimmed post-call as analysts push the 'inflection' further into H2 and haircut confidence in the '180' casualty-book and Accession-synergy offsets, while continued Howden litigation bleed and elevated leverage keep the credibility question (raised by Morgan Stanley's downgrade) alive - producing a grinding downward drift over the week rather than a snap-back.",
  "day5_confidence": "MEDIUM"
}